Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz vs. Tenofovir in HIV-1 Infection
NCT00053638Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2003
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of efavirenz, tenofovir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by GSK. Started Feb 2003; status: completed.
02
Drugs
efavirenztenofovir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00053638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053638.